Teva Branded Pharmaceutical Products R&d Llc

This early-stage study tested the safety and initial effectiveness of a new drug, modakafusp alfa, when given alongside an existing drug, daratumumab, for people with multiple myeloma that has returned or stopped responding to other treatments. The main goal was to find a safe do…

This early-phase study tested the safety and initial effectiveness of a new drug called modakafusp alfa, both alone and combined with an existing immunotherapy (pembrolizumab), in adults with advanced solid tumors or melanoma. The main goals were to find a safe dose and check for…

This study tested a new drug called modakafusp alfa for people with multiple myeloma, a type of blood cancer, that had returned or stopped responding to at least three prior treatments. The main goals were to find a safe and effective dose and to see if the drug could help contro…

This early-stage study aimed to find a safe dose and check for side effects of a new drug, modakafusp alfa, when given with other approved myeloma medications. It involved adults with multiple myeloma, including those newly diagnosed after a stem cell transplant and those whose c…